Dr David Welsh

  • Research Fellow (Institute of Cardiovascular and Medical Sciences)

telephone: 01412112187
email: David.Welsh@glasgow.ac.uk

Level 8
Scottish Pulmonary Vascular Unit
Western Infirmary


List all by: Type | Date

Jump to: 2012 | 2009 | 2008 | 2007
Number of items: 5.

2012

Carlin , C., Celnik, D., Pak, O., Wadsworth, R., Peacock, A., and Welsh, D. (2012) Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 47 (2). pp. 140-148. ISSN 1044-1549 (doi:10.1165/rcmb.2011-0411OC)

2009

Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., and Peacock, A. J. (2009) Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. AJP: Heart and Circulatory Physiology, 296 (5). H1312-H1320. ISSN 0363-6135 (doi:10.1152/ajpheart.00977.2008)

2008

Dempsie, Y. et al. (2008) Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice. Circulation, 117 (22). pp. 2928-2937. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.767558)

Syyed, R., Reeves, J. T., Welsh, D., Raeside, D., Johnson, M. K., and Peacock, A. J. (2008) The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease. Chest, 133 (3). pp. 633-639. ISSN 0012-3692 (doi:10.1378/chest.07-1367)

2007

Carlin, C., Peacock, A., and Welsh, D. (2007) Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 37 (4). pp. 447-456. ISSN 1044-1549 (doi:10.1165/rcmb.2007-0012OC)

This list was generated on Thu Apr 24 02:45:49 2014 BST.
Jump to: Article
Number of items: 5.

Article

Carlin , C., Celnik, D., Pak, O., Wadsworth, R., Peacock, A., and Welsh, D. (2012) Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology, 47 (2). pp. 140-148. ISSN 1044-1549 (doi:10.1165/rcmb.2011-0411OC)

Weerackody, R. P., Welsh, D. J., Wadsworth, R. M., and Peacock, A. J. (2009) Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction. AJP: Heart and Circulatory Physiology, 296 (5). H1312-H1320. ISSN 0363-6135 (doi:10.1152/ajpheart.00977.2008)

Dempsie, Y. et al. (2008) Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice. Circulation, 117 (22). pp. 2928-2937. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.767558)

Syyed, R., Reeves, J. T., Welsh, D., Raeside, D., Johnson, M. K., and Peacock, A. J. (2008) The Relationship Between the Components of Pulmonary Artery Pressure Remains Constant Under All Conditions in Both Health and Disease. Chest, 133 (3). pp. 633-639. ISSN 0012-3692 (doi:10.1378/chest.07-1367)

Carlin, C., Peacock, A., and Welsh, D. (2007) Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 37 (4). pp. 447-456. ISSN 1044-1549 (doi:10.1165/rcmb.2007-0012OC)

This list was generated on Thu Apr 24 02:45:49 2014 BST.

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Acute Pulmonary Haemodynamic Effects of Apelin in Pulmonary Hypertension
    British Heart Foundation
    2012 - 2014
     
  • Role of the fibroblast in pulmonary vascular remodelling: paracrine signalling and molecular mechanisms
    Wellcome Trust
    2009 - 2012